
Periwinkle Technologies
Healthcare & MedTech
DeepTech
Maharashtra
, India
Founded:
Jan 2013
Founders:
Koustubh Naik, Veena Moktali
Description:
AI-enabled, FDA-cleared cervical cancer screening and triage platform delivering risk assessment in under 60 seconds.
Key Highlights:
Funds Raised: ~$0.5M
Cervical Cancer Screenings: 450k+
FY26 Revenue: ~$2M
Granted Patents: 6
User Sites across 3 Continents: 1000+
Core Problem Statement
Slow, fragmented triage workflows and infrastructure gaps delay clinical intervention in cervical cancer care, which is a leading cause of cancer deaths in women globally.
Solution Overview
An AI-enabled, FDA-cleared cervical cancer screening and triage platform. It includes an electricity-free cervical imaging device enabling single-visit screening and an AI-enabled app for real-time risk assessment in under 60 seconds, supported by a cloud-based telemedicine platform for remote specialist consultation.
Strategic Engagement Opportunities
The clinically validated Smart Scope® CX and AI triage platform position Periwinkle as a strong translational partner for cancer research institutes and reproductive health assessment pilots. It is also a candidate for public health grants focused on improving population-level cervical cancer outcomes.
